Action of a Proteolytic Enzyme Inhibitor on Blood Coagulation in Vitro

Summary

The action of the kallikrein and trypsin inhibitor, Trasylol, has been studied in a three-stage thrombin generation system. It has been found that Trasylol inhibits one or several of the early reactions of blood coagulation. The inhibition of the early stages is dependent on the concentration of inhibitor, serum factors and factor VIII. The activation of factor V by tiger snake venom is not inhibited by Trasylol. The inhibition is most probably on one or several of the reactions preceding the factor V involved step.

Some other known antifibrinolytic agents have also been tested for anti-coagulation activity.

• References

• 1 Kunitz M, Northrop J. H. Isolation from beef pancreas of crystalline trypsinogen, trypsin, trypsin-inhibitor and an inhibitor-trypsin compound. J. gen. Physiol. 19: 991 1936;
• 2 Frey E. K, Kraut H. Ein neues Kreislaufhormon und seine Wirkung. Arch. exp. Path. Pharm. 133: 1 1928;
• 3 Anderer F. A. Strukturuntersuchungen am Kallikrein-Inaktivator aus Rinderlunge. II. Bestimmung der Aminosäuresequenz. Z. Naturforsch 20b: 462 1965;
• 4 Kassel B, Laskowski Sr M. The basic trypsin inhibitor of bovine pancreas. III. A progress report on the tryptic peptides. Biochem. biophys. Res. Commun. 17: 792 1964;
• 5 Chauvet J, Nouvel G, Acher R. Structure primaire d’un inhibiteur pancréatique de la trypsine (Inhibiteur de Kunitz et Northrop. Biochim. biophys. Acta (Amst) 115: 130 1966;
• 6 Werle E, Maier L, Ringelmann E. Hemmung von Proteinasen durch Kallikrein-Inaktivatoren. Naturwissensch 39: 328 1952;
• 7 Kraut H, Körbel-Enkhardt R. Das Verhalten des Kallikrein-Inaktivators aus Rinderparotis gegenüber proteolytischen Fermenten. Leistungen und Ergebnisse der neuzeitlichen Chirurgie. 62-68 Thieme, Stuttgart: 1958
• 8 Marx R, Clemente P, Werle E, Appel W. Zum Problem eines Antidotes in der internen Thrombotherapie mit Fibrinolytika. Blut. 05: 367 1959;
• 9 Olsson P, Nordstrom S. The significance of postoperative variations in antithrombin. Thoraxchirurgie. 12: 176 1964;
• 10 Nordstrom S, Olsson P, Blombäck M. Thromboplastin induced hypercoagulability and its prevention. Nature (Lond) 206: 632 1965;
• 11 Soulier J. P. Proteolytic enzyme inhibitors. Their action on blood coagulation and fibrinolysis. Anticoagulants and fibrinolysins. 403 Macmillan of Canada: 1961
• 12 Teger-Nilsson A-G. A procoagulant from retroplacental serum and its relation to factor X. Abstr. Xth Congr. Int. Soc. Haematol. Stockholm, Sweden; 1964. G: 32.
• 13 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Arkiv Kemi. 10 4: 15 1956;
• 14 Blombäck B, Blombäck M. A method for the assay of factor V. Scand. J. clin. Lab. Invest 15: 639 1963;
• 15 Blombäck B, Blombäck M, Francken I. v. Disc. Conf. Int. Com. Blood Clotting Factors, Stockholm, 1962. Thrombos. Diathes. haemorrh. (Stuttg) 09 Suppl. 2, 233 1963;
• 16 Teger-Nilsson A-G. To be published..
• 17 Blombäck B, Blombäck M. To the discussion on genetics and the interaction of blood clotting factors. Conf. Int. Com. Blood Clotting Factors, Amsterdam 1964. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl. 17: 59 1965;
• 18 Hirs G. H. W. The oxidation of ribonuclease with performic acid. J. biol. Chem. 219: 611 1965;
• 19 Brown W. D. Reduction of protein disulfide bonds by sodium borohydride. Biochim. biophys. Acta (Amst) 44: 365 1960;
• 20 Niewiarowski S, Stachurska J, Wegrzynowicz Z. Arginine esterase activity of the contact (Hageman) factor. Thrombos. Diathes. haemorrh. (Stuttg) 07: 514 1962;
• 21 Kingdon H. S, Davie E. W, Ratnojf O. D. The reaction between activated plasma thromboplastin antecedent and diisopropylphosphofluoridate. Biochemistry 03: 166 1964;
• 22 Esnouf M. P, Williams W. J. The isolation and purification of bovine-plasma-protein which is a substrate for the coagulant fraction of Russel’s-Viper Venom. Biochem. J. 84: 62 1962;
• 23 Amris C. J. Inhibition of fibrinolytic and thromboplastic activity by Trasylol. Scand. J. Haemat. 03: 19 1966;
• 24 Herschlein H. J, Steichele D. F. Die Hemmung der Hyperkoagulabilität des Blutes. Med. Welt (Stuttg) 1964; 1314.